Terrie Curran News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Catalys Pacific LLC Makes New Investment in Phathom Pharmaceuticals, Inc (NASDAQ:PHAT)

Catalys Pacific LLC purchased a new position in shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 721,962 shares of the company’s stock, valued at approximately $6,592,000. Phathom Pharmaceuticals accounts for about 6.2% of […]

United statesNew zealand generalNew zealandTerrie curranStifel nicolausMolly hendersonCatalys pacificNews ratings for phathom pharmaceuticals dailyPhathom pharmaceuticals stock performanceQuarter for phathom pharmaceuticalsPhathom pharmaceuticals incPrincipal financial group incInsider activity at phathom pharmaceuticalsBarclays plcSecurities exchange commissionWellington management group

Decheng Capital LLC Purchases Shares of 850,000 Phathom Pharmaceuticals, Inc (NASDAQ:PHAT)

Decheng Capital LLC Purchases Shares of 850,000 Phathom Pharmaceuticals, Inc (NASDAQ:PHAT)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesMolly hendersonStifel nicolausTerrie curranNews ratings for phathom pharmaceuticals dailyPhathom pharmaceuticalsInsider transactions at phathom pharmaceuticalsPhathom pharmaceuticals incDecheng capitalKennedy capital managementNeedham companySecurities exchange commissionPhathom pharmaceuticals stock performanceCapital partnersQuarter for phathom pharmaceuticalsVanguard group inc

850,000 Shares in Phathom Pharmaceuticals, Inc (NASDAQ:PHAT) Acquired by Decheng Capital LLC

850,000 Shares in Phathom Pharmaceuticals, Inc (NASDAQ:PHAT) Acquired by Decheng Capital LLC
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesStifel nicolausMolly hendersonZurcher kantonalbank zurich cantonalbankTerrie curranDecheng capitalPrincipal financial group incInsider transactions at phathom pharmaceuticalsPhathom pharmaceuticals incNeedham companyPhathom pharmaceuticals company profileNews ratings for phathom pharmaceuticals dailyPhathom pharmaceuticalsChina universal asset management coQuarter for phathom pharmaceuticalsPhathom pharmaceuticals stock performance

Phathom Pharmaceuticals (NASDAQ:PHAT) Receives Buy Rating from Needham & Company LLC

Phathom Pharmaceuticals (NASDAQ:PHAT) Receives Buy Rating from Needham & Company LLC
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesMolly hendersonStifel nicolausTerrie curranZurcher kantonalbank zurich cantonalbankPhathom pharmaceuticalsKlingman associatesInstitutional trading of phathom pharmaceuticalsSecurities exchange commissionNeedham companyChina universal asset management coPhathom pharmaceuticals incNews ratings for phathom pharmaceuticals dailyPhathom pharmaceuticals company profilePhathom pharmaceuticals stock performanceGet free report

Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Up 11 8%

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report)’s share price shot up 11.8% during mid-day trading on Monday . The company traded as high as $11.23 and last traded at $11.22. 489,633 shares were traded during trading, a decline of 40% from the average session volume of 809,964 shares. The stock had previously closed at […]

United statesTerrie curranMolly hendersonStifel nicolausInvesco ltdPhathom pharmaceuticalsHedge funds weigh in on phathom pharmaceuticalsNews ratings for phathom pharmaceuticals dailyNeedham companyPhathom pharmaceuticals incAlgert globalChina universal asset management coSg americas securitiesPhathom pharmaceuticals price performanceSecurities exchange commissionVanguard group inc